The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy

Clinical Cancer Research

Volumn 6, Issue 12, 2000, Pages 4866-4873

  Inoue, Keiji ^a,b   Slaton, Joel W ^a   Karashima, Takashi ^b   Yoshikawa, Chiaki ^b   Shuin, Taro ^b   Sweeney, Paul ^a   Millikan, Randall ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CISPLATIN; DOXORUBICIN; INTERLEUKIN 8; METHOTREXATE; VASCULOTROPIN; VINBLASTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYSTECTOMY; DISEASE-FREE SURVIVAL; DOXORUBICIN; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-8; LYMPHOKINES; MALE; METHOTREXATE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; RECURRENCE; RNA, MESSENGER; TIME FACTORS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VINBLASTINE;

EID: 0034489115     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Cancer statistics
2. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
3. Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy
4. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium
5. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse
6. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
7. Angiogenesis: Initiation and modulation
8. Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma
9. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line
10. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
11. Different angiogenic pathways characterize superficial and invasive bladder cancer
12. Constitutive production of multiple cytokines and a human chorionic gonadotrophin β-subunit by a human bladder cancer cell line (KU-19-19): Possible demonstration of totipotential differentiation
13. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas
14. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
15. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder
16. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor
17. Interleukin-8 expression regulates tumorigenicity and metastasis in human bladder cancer
18. Bladder
19. Basic fibroblast growth factor fused to a signal peptide transforms cells
20. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
21. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells
22. A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells
23. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas
24. Complete one-hour immunocytochemistry based on capillary action
25. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice
26. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma
27. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
28. The significance of atypical vessels and neovascularization in cervical endoplasia
29. Relation of neovascularization to metastasis in non-small cell lung cancer
30. Tumor angiogenesis correlates with metastasis in invasive prostate cancer
31. Intratumoral microvessel density and p53 protein: Correlation with metastasis in head-and-neck squamous cell carcinoma
32. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
33. Molecular determinants of angiogenesis in cancer metastasis
34. Angiogenic molecules and cancer metastasis
35. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rate
36. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
37. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
38. Accumulation of nuclear p53 and tumor progression in bladder cancer
39. Overexpression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value
40. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC
41. Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas
42. Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line
43. Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anti-cancer drugs
44. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
45. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line
46. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor